Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Mesenchymal Chondrosarcoma – Symptoms, Treatment & Support

What is Mesenchymal Chondrosarcoma? Mesenchymal chondrosarcoma is a rare and aggressive form of cancer that arises from cartilage-producing tissues. This type of chondrosarcoma is unique due to its mesenchymal origin, meaning it comes from connective tissue, and is...

Pleomorphic Rhabdomyosarcoma – Symptoms, Treatment & Support

What is Pleomorphic Rhabdomyosarcoma? Pleomorphic rhabdomyosarcoma is a rare and aggressive form of soft tissue cancer. It’s part of the rhabdomyosarcoma family, cancers that develop from skeletal muscle cells. Pleomorphic rhabdomyosarcoma is characterized by...

Malignant Extrarenal Rhabdoid Tumour – Symptoms, Treatment & Support

What is Malignant Extrarenal Rhabdoid Tumour? Malignant extrarenal rhabdoid tumour (MERT) is a rare and highly aggressive cancer that originates outside of the kidneys. Rhabdoid tumours were first identified in the kidneys but can occur in other soft tissues...

Primary Cutaneous Marginal Zone B-cell Lymphoma – Symptoms, Treatment & Support

What is Primary Cutaneous Marginal Zone B-cell Lymphoma? Primary cutaneous marginal zone B-cell lymphoma (PCMZL) is a rare type of low-grade skin lymphoma. It belongs to the group of indolent (slow-growing) non-Hodgkin lymphomas and primarily affects the skin, with a...

Post-Transplant Lymphoproliferative Disorders – Symptoms, Treatment & Support

What are Post-Transplant Lymphoproliferative Disorders (PTLD)? Post-transplant lymphoproliferative disorders (PTLD) are a group of conditions that may occur after an organ or stem cell transplant. These disorders are characterized by an uncontrolled proliferation of...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter